APPOINTMENTS (480) 626–2727
AT ASU RESEARCH PARK

Ketamine and Diabetic Neuropathy

All diabetics are at risk of developing Diabetic Neuropathy, painful nerve damage that results from high blood sugar levels (29.1 million in America—and rising—according to the American Diabetes Association). Most at risk, however, might be the estimated 8.1 million Americans who don’t even realize they have diabetes, and so don’t know how badly their high blood sugar levels are hurting them.

While the mechanism isn’t perfectly understood, it appears that high blood glucose levels impair nerve signals, as well as weaken the walls of blood vessels that feed the nerves, leading to potentially severe nerve damage. Symptoms can include numbness and loss of feeling, muscle weakness and loss of coordination, ulcers, deformities, and a host of other symptoms—including agonizing pain. The digestive system, urinary tract, blood vessels and heart are all at risk, but legs and feet are most often affected.

Ketamine, as part of a multi-modal treatment regimen, may help to provide relief and improve symptoms in Diabetic Neuropathy in as little as one treatment. Research studies have shown that Ketamine can help to reduce the experience of pain by blocking, among other things, NMDA receptors, preventing an excitatory neurotransmitter called glutamate from initiating the perception of pain. As well, Ketamine also possesses some neurogenic qualities, meaning that it can help to stimulate healing and regrowth in nerve tissues.

Medically-supervised Ketamine infusions could help you regain tissue health and function. If you are struggling with Diabetic Neuropathy, Ketamine Infusion for Pain Relief Institute (KIPRI) can help you take back control of your life.

Contact Us

Contact Us
First
Last